| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |